Yi Ba
ORCID: 0009-0002-9631-5228
· 1 paper in corpus
BRAF mutant colorectal cancer (CRC) is highly aggressive and often resistant to traditional therapies, presenting a significant challenge in cancer immunotherapy. Understanding the tumor microenvironment (TME) and identifying novel immune c…